Genetic testing in familial melanoma: uptake and implications

Objective: We report on the uptake and psychological impact of p16‐Leiden genetic testing to contribute to a greater understanding of counseling melanoma families. Methods: Within a defined research setting, genetic counseling and testing were offered to members of p16‐Leiden‐positive melanoma pedig...

Full description

Saved in:
Bibliographic Details
Published inPsycho-oncology (Chichester, England) Vol. 17; no. 8; pp. 790 - 796
Main Authors de Snoo, Femke A., Riedijk, Samantha R., van Mil, Anneke M., Bergman, Wilma, ter Huurne, Jeanet A.C., Timman, Reinier, Bertina, Wieke, Gruis, Nelleke A., Vasen, Hans F.A., van Haeringen, Arie, Breuning, Martijn H., Tibben, Aad
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.08.2008
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective: We report on the uptake and psychological impact of p16‐Leiden genetic testing to contribute to a greater understanding of counseling melanoma families. Methods: Within a defined research setting, genetic counseling and testing were offered to members of p16‐Leiden‐positive melanoma pedigrees, at risk of carrying a gene defect associated with an increased risk of melanoma and pancreatic cancer. Results: One hundred and eighty‐four individuals sought counseling, of which 141 (77%) opted for genetic testing. Uptake of genetic counseling and testing, and psychological motivation was evaluated in 94 (57%) individuals. Higher pre‐test risk of carrying the mutation and older age proved significantly predictive for counseling uptake. Age was predictive for test acceptance, whereas fearful test expectancies predicted test decline. Counselees had lower distress levels than those reported in other oncogenetic testing settings. Conclusion: We are the first to report on genetic testing for familial melanoma. Following the first counseling session, we found a relatively high uptake rate for p16‐Leiden testing and no clinically worrisome levels of distress. Copyright © 2008 John Wiley & Sons, Ltd.
Bibliography:ArticleID:PON1377
istex:D98A9F0103EEB71C68C0FE120A8CC0E5C48F61F9
ark:/67375/WNG-RVFZZN2H-C
Femke A. de Snoo and Samantha R. Riedijk contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1057-9249
1099-1611
DOI:10.1002/pon.1377